Digital Pathology Today™ is your podcast all about the world of digital pathology.  Each week, we talk with industry leaders, key academics, top pathologists and more to discover the past, present and future of digital pathology.  Join us every week for another look at Digital Pathology Today™.

Hosted by pathologist Dr. Joseph Anderson.

Current Episode

Season 3, Episode 13

Personalizing Treatment Decisions 

Through Artificial Intelligence 

This episode of Digital Pathology Today™ our guest is Andre Esteva, Ph.D , Founder and CEO of Artera.  

Today we are discussing how treatment decisions can be personalized through artificial intelligence and digital pathology. Atera’s first product is in prostate cancer.   We discuss how AI can improve upon the current state of the practice which largely relies on making decisions based on clinical nomograms.

We discuss the concepts prediction and prognosis and how both are incorporated into treatment decisions; what goes into developing and validating AI based algorithms in digital pathology and the importance of validating these algorithms in the appropriate studies specifically randomized clinical trials. 

There is one huge advantage of AI based digital pathology tools over genomics and molecular tools.   Image based tools can be performed instantaneously rather than waiting days to weeks.

Andre Esteva is a researcher and entrepreneur in medical artificial intelligence. He currently serves as CEO of Artera and was previously Head of Medical AI at Salesforce Research. He has worked at Google Research, Sandia National Labs, GE Healthcare, and has founded four companies.

His research efforts have largely focused on medical AI diagnostics and precision medicine. His publications have made the covers of Nature and Nature Medicine, and have been featured in Cell, The Lancet, NeurIPS, and similar venues. These works have been widely covered by the WSJ, Fortune, BBC, The Economist, and hundreds of other news outlets.

All opinions and views expressed on Digital Pathology Today™ are those of the individual expressing them.  No guests have paid nor been paid for their appearance on Digital Pathology Today™.   Digital Pathology Today™ does not endorse any specific products or technologies mentioned on the show.